2020 Dravet Syndrome Foundation Conference Registration Open
Dravet Syndrome Foundation has announced that registration for this year's DSF Conference is now open.
Phase 3b Trial of Aducanumab, Autoinjector FDA Approved for Fremanezumab, Ticagrelor Phase 3 Trial Announced
Neurology News Network for the week ending February 1, 2020.
NeurologyLive Friday 5 — January 31, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 31, 2020.
NDA Submission for Cataplexy Treatment, Siponimod Approved by EU for Progressive Multiple Sclerosis, RimabotulinumtoxinB Approved for Sialorrhea in Adults
Neurology News Network for the week ending January 27, 2020.
NeurologyLive Friday 5 — January 24, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 24, 2020.
FDA Approves Intranasal Diazepam, Rimegepant and Erenumab Effectively Treats Refractory Migraine, MS Treatments Double Since 2011
Neurology News Network for the week ending January 18, 2020.
NeurologyLive Friday 5 — January 17, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 17, 2020.
New Neuroimaging Guidelines for Migraine, Lemborexant Improves Sleep Onset, Patients with Parkinsons Have Compromised Swimming Ability
Neurology News Network for the week ending January 11, 2020.
Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short
Neurology News Network for the week ending January 4, 2020.
Amylyx Announces ALS Investigational Agent, FDA Approves Golodirsen for DMD, Wave Life Sciences Discontinues Suvodirsen, Discontinuation of Gosuranemab
Neurology News Network for the week ending December 21, 2019.
CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency
Neurology News Network for the week ending December 14, 2019.
FDA Grants Breakthrough Designation for RightEye Vision System, Results from ESETT Trial Released, Conference Coverage of the 73rd Annual Meeting of the American Epilepsy Society
Neurology News Network for the week ending December 7, 2019.
Dravet Syndrome Foundation Hosts Research Roundtable at AES 2019
The 10th annual DSF Research Roundtable will take place on Thursday, December 5, in Baltimore, Maryland.
FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS
Neurology News Network for the week ending November 30, 2019.
Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia
Neurology News Network for the week ending November 23, 2019.
Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies
Neurology News Network for the week ending November 16, 2019.
Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD
Neurology News Network for the week ending November 9, 2019.
Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold
Neurology News Network for the week ending October 28, 2019.
Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus
Neurology News Network for the week ending October 26, 2019.
Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia
Neurology News Network for the week ending October 19, 2019.
Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers
Neurology News Network for the week ending October 12, 2019.
RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data
Neurology News Network for the week ending October 5, 2019.
Are Multiple Sclerosis Treatment Prices Interfering With Patient Care?
Unsustainable costs pose challenges for patients and providers alike as the price of living with MS continues to rise.
EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD
Neurology News Network for the week ending September 28, 2019.
STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data
Neurology News Network for the week ending September 21, 2019.
NeurologyLive Adds Montefiore Health System to Its Strategic Alliance Partnership Program
Montefiore Health System will also be working with The American Journal for Managed Care.
Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019
Neurology News Network for the week ending September 14, 2019.
MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound
Neurology News Network for the week ending September 7, 2019.
Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy
Neurology News Network for the week ending August 31, 2019.
FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update
Neurology News Network for the week ending August 24, 2019.